Symbol Name ID |
Ptgs2
prostaglandin-endoperoxide synthase 2 MGI:97798 |
* | Aspects of the system are reported to show a normal phenotype. |
! | Indicates phenotype varies with strain background. |
Darker colors indicate more annotations |
Human Phenotypes | Increased circulating antibody level |
Hypercalcemia |
Elevated circulating C-reactive protein concentration |
Increased CSF protein concentration |
Elevated circulating hepatic transaminase concentration |
Elevated erythrocyte sedimentation rate |
Diabetes mellitus |
Elevated sweat chloride |
Dehydration |
Joint swelling |
Pleural effusion |
Chylothorax |
Fever |
Hypothermia |
Hypercalciuria |
Scarring |
Disease(s) Associated with PTGS2 | ||||||||||||||||
cystic fibrosis | ||||||||||||||||
idiopathic pulmonary fibrosis | ||||||||||||||||
pancreatic cancer | ||||||||||||||||
rheumatoid arthritis | ||||||||||||||||
sarcoidosis |
Mouse Phenotypes | homeostasis/metabolism phenotype |
impaired exercise endurance |
abnormal response of heart to induced stress |
decreased susceptibility to neuronal excitotoxicity |
increased susceptibility to neuronal excitotoxicity |
intestinal edema |
increased susceptibility to diet-induced obesity |
decreased platelet calcium level |
abnormal platelet physiology |
increased platelet aggregation |
increased circulating creatinine level |
increased blood urea nitrogen level |
increased circulating follicle stimulating hormone level |
increased circulating luteinizing hormone level |
increased circulating insulin level |
increased circulating leptin level |
abnormal blood coagulation |
abnormal thrombolysis |
abnormal thrombosis |
decreased susceptibility to induced thrombosis |
increased susceptibility to induced thrombosis |
impaired febrile response |
abnormal enzyme/coenzyme level |
decreased lactate dehydrogenase level |
abnormal lipid homeostasis |
decreased prostaglandin level |
increased prostaglandin level |
abnormal urine homeostasis |
decreased urine prostaglandin level |
increased urine prostaglandin level |
albuminuria |
abnormal response/metabolism to endogenous compounds |
increased susceptibility to xenobiotic induced morbidity/mortality |
decreased physiological sensitivity to xenobiotic |
decreased incidence of tumors by chemical induction |
increased incidence of tumors by chemical induction |
abnormal response to injury |
abnormal response to CNS ischemic injury |
decreased cerebral infarct size |
abnormal wound healing |
abnormal bone healing |
decreased susceptibility to injury |
increased susceptibility to injury |
|
Availability | Mouse Genotype | |||||||||||||||||||||||||||||||||||||||||||
Ptgs2tm1.1Fun/Ptgs2tm1.1Fun | ||||||||||||||||||||||||||||||||||||||||||||
Ptgs2tm1.1Wls/Ptgs2tm1.1Wls | ||||||||||||||||||||||||||||||||||||||||||||
Ptgs2tm1Fun/Ptgs2tm1Fun | ||||||||||||||||||||||||||||||||||||||||||||
Ptgs2tm1Jed/Ptgs2tm1Jed | * | |||||||||||||||||||||||||||||||||||||||||||
Ptgs2tm1Unc/Ptgs2tm1Unc | * | ! | ||||||||||||||||||||||||||||||||||||||||||
Ptgs2tm3Fun/Ptgs2tm3Fun | ||||||||||||||||||||||||||||||||||||||||||||
Ptgs2tm1Unc/Ptgs2+ | ||||||||||||||||||||||||||||||||||||||||||||
Ptgs2tm1Unc/Ptgs2tm2.1Hahe | ||||||||||||||||||||||||||||||||||||||||||||
Tg(K5-Ptgs2)19Kmd/0 | ||||||||||||||||||||||||||||||||||||||||||||
Tg(K5-Ptgs2)667Kmd/0 | ||||||||||||||||||||||||||||||||||||||||||||
Tg(K5-Ptgs2)675Kmd/0 | ||||||||||||||||||||||||||||||||||||||||||||
Tg(Nphs1-Ptgs2)14Rhrs/0 | ||||||||||||||||||||||||||||||||||||||||||||
Ptgs2tm1Gaf/Ptgs2tm1Gaf A1cfTg(Myh6-cre/Esr1*)1Jmk/? (conditional) |
||||||||||||||||||||||||||||||||||||||||||||
Ptgs2tm1Wlf/Ptgs2tm1Wlf Tg(Nes-cre)1Kln/0 (conditional) |
* |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 04/23/2024 MGI 6.23 |
|
|